Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
Iran: According to a study published in Diabetology and Metabolic Syndrome, triglycerides are elevated in normoglycemic patients.
Read Full NewsTransforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols
Not surprisingly, trust in government health agencies for cancer info has dipped
Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC
News, features, and commentary about cancer-related issues
Observational study shows greater microplastic burden in patients with lung malignancy
Health news and commentary gathered by MedPage Today staff
The health ramifications of the attack persist
1.
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer
2.
Atezolizumab + Cabozantinib Postpones mCRPC Progression.
3.
In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.
4.
Survey: Record Numbers of US Adults Report Depression.
5.
FDA Approves Hemophilia B Second Gene Therapy.
1.
Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System
2.
Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma
3.
Modern Concepts in Oncology Across Clinical Settings
4.
Rehabilitation of Functional Capacity Following Cancer-Related Prolonged Deconditioning
5.
Learning from Uncommon Inherited Bleeding Disorder Presentations
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
How Hematologists Evaluate Persistent Blood Abnormalities
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
5.
Early Cancer Detection Saves Lives
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge